Acute Promyelocytic Leukemia: Recent Advances in Diagnosis and Management
- 31 August 2008
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 35 (4), 401-409
- https://doi.org/10.1053/j.seminoncol.2008.04.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicityBlood, 2006
- Management of APL in Developing Countries: Epidemiology, Challenges and Opportunities for International CollaborationHematology-American Society Hematology Education Program, 2006
- Treatment of Acute Promyelocytic LeukemiaHematology-American Society Hematology Education Program, 2006
- Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemiaBlood, 2005
- Practice Points, Consensus, and Controversial Issues in the Management of Patients with Newly Diagnosed Acute Promyelocytic LeukemiaThe Oncologist, 2005
- Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemiaBlood, 2004
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupBlood, 2003
- Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemiaLeukemia, 2002
- ADVANCESINTHE UNDERSTANDINGAND MANAGEMENTOF ACUTE PROMYELOCYTIC LEUKEMIAReviews in Clinical and Experimental Hematology, 2002